These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12530194)

  • 1. [Cochlear cytotoxic activity of cisplatin in experimentation animals. A study using scanning electron microscopy].
    Ramírez Camacho R; García Berrocal JR; Trinidad A; Martín Marero A; Buján J
    Acta Otorrinolaringol Esp; 2002 Oct; 53(8):538-42. PubMed ID: 12530194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amifostine otoprotection to cisplatin ototoxicity: a guinea pig study using otoacoustic emission distortion products (DPOEA) and scanning electron microscopy].
    Hyppolito MA; de Oliveira AA; Lessa RM; Rossato M
    Braz J Otorhinolaryngol; 2005; 71(3):268-73. PubMed ID: 16446928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ototoxicity of the new platinum anticancer agent TRK-710 in comparison with cisplatin.
    Saito T; Manabe Y; Saito H
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):250-5. PubMed ID: 8587776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supporting cells as a target of cisplatin-induced inner ear damage: therapeutic implications.
    Ramírez-Camacho R; García-Berrocal JR; Buján J; Martín-Marero A; Trinidad A
    Laryngoscope; 2004 Mar; 114(3):533-7. PubMed ID: 15091230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs.
    Shafik AG; Elkabarity RH; Thabet MT; Soliman NB; Kalleny NK
    Auris Nasus Larynx; 2013 Feb; 40(1):51-60. PubMed ID: 22884636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
    Schweitzer VG
    Laryngoscope; 1993 Apr; 103(4 Pt 2):1-52. PubMed ID: 8464301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of caspase-activated deoxyribonuclease (CAD) and caspase 3 (CPP32) in the cochlea of cisplatin (CDDP)-treated guinea pigs.
    Watanabe K; Inai S; Jinnouchi K; Baba S; Yagi T
    Auris Nasus Larynx; 2003 Aug; 30(3):219-25. PubMed ID: 12927282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental studies of the protective effect of deferoxamine mesilate on cisplatin induced toxicity].
    Watanabe H; Kanno H
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Aug; 101(8):967-78. PubMed ID: 9778942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of Maytenus ilicifolia to prevent cisplatin-induced ototoxicity.
    Kasse CA; Cruz OLM; Iha LCN; Costa HO; Lopes EC; Coelho F
    Braz J Otorhinolaryngol; 2008; 74(5):712-717. PubMed ID: 19082353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiquantitative analysis by scanning electron microscopy of cochlear hair cell damage by ototoxic drugs.
    Saito T; Manabe Y; Honda N; Yamada T; Yamamoto T; Saito H
    Scanning Microsc; 1995 Mar; 9(1):271-80; discussion 280-1. PubMed ID: 8553022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural changes in the albino guinea pig cochlea at different survival times following cessation of 8-day cisplatin administration.
    Cardinaal RM; De Groot JC; Huizing EH; Smoorenburg GF; Veldman JE
    Acta Otolaryngol; 2004 Mar; 124(2):144-54. PubMed ID: 15072416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cochlear damage by nitromin or cisplatin and the influence of steroid hormone].
    Kawade K; Yokoi H; Yanagita N
    Nihon Jibiinkoka Gakkai Kaiho; 1986 Feb; 89(2):177-91. PubMed ID: 3086528
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of antioxidants in protection from ototoxic drugs.
    Sergi B; Fetoni AR; Ferraresi A; Troiani D; Azzena GB; Paludetti G; Maurizi M
    Acta Otolaryngol Suppl; 2004 May; (552):42-5. PubMed ID: 15219046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent cochlear and vestibular toxicity of trans-tympanic cisplatin in the rat.
    Callejo A; Durochat A; Bressieux S; Saleur A; Chabbert C; Domènech Juan I; Llorens J; Gaboyard-Niay S
    Neurotoxicology; 2017 May; 60():1-9. PubMed ID: 28223157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of 1,2,3-triazole derivative KPR-A020 against cisplatin-induced ototoxicity in murine cochlear cultures.
    Kim YR; Jung DJ; Oh SK; Lee T; Lee IK; Lee KY; Kim UK
    Int J Pediatr Otorhinolaryngol; 2017 May; 96():59-64. PubMed ID: 28390615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the kidney injury molecule 1 in the rat cochlea and induction by cisplatin.
    Mukherjea D; Whitworth CA; Nandish S; Dunaway GA; Rybak LP; Ramkumar V
    Neuroscience; 2006 May; 139(2):733-40. PubMed ID: 16464536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ototoxicity resulting from combined administration of cisplatin and gentamicin.
    Kohn S; Fradis M; Podoshin L; David YB; Zidan J; Robinson E; Nir I
    Laryngoscope; 1997 Mar; 107(3):407-8. PubMed ID: 9121325
    [No Abstract]   [Full Text] [Related]  

  • 18. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
    Huang X; Whitworth CA; Rybak LP
    Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of cisplatin ototoxicity by otoprotective effects of nanoencapsulated curcumin and dexamethasone in a guinea pig model.
    Salehi P; Akinpelu OV; Waissbluth S; Peleva E; Meehan B; Rak J; Daniel SJ
    Otol Neurotol; 2014 Aug; 35(7):1131-9. PubMed ID: 24841915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ototoxicity of the anticancer drug cisplatin. An experimental study.
    Nakai Y; Konishi K; Chang KC; Ohashi K; Morisaki N; Minowa Y; Morimoto A
    Acta Otolaryngol; 1982; 93(1-6):227-32. PubMed ID: 7199807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.